| | |
Aged 65 and above
|
Entire SHI population
|
Ratio aged ≥65 and entire SHI
|
---|
No.
|
ATC-Code
|
Agent
|
DDD (in Mio.) ≥65 years
|
Prescriptions ≥65 (in Mio.)
|
Sales ≥65 (in Mio. €)
|
Costs per DDD ≥65
|
Total DDD (in Mio)
|
Total prescriptions (in Mio)
|
Total sales (in Mio. €)
|
Costs per DDD
|
DDD
|
Prescriptions
|
Sales
|
---|
1
|
C02CA04
|
Doxazosin
|
51.4
|
0.56
|
19.5
|
0.38 €
|
60.2
|
0.81
|
28.1
|
0.38 €
|
85.38 %
|
69.47 %
|
69.37 %
|
2
|
N06AA09
|
Amitriptyline
|
45.7
|
1.13
|
19.8
|
0.43 €
|
94.5
|
2.28
|
40.5
|
0.43 €
|
48.36 %
|
49.66 %
|
48.88 %
|
3
|
C07AA07
|
Sotalol
|
34.0
|
0.53
|
10.2
|
0.30 €
|
36.6
|
0.68
|
13.0
|
0.30 €
|
92.90 %
|
78.39 %
|
78.56 %
|
4
|
C01AA02
|
Acetyldigoxin
|
32.5
|
0.93
|
11.7
|
0.36 €
|
36.4
|
1.05
|
13.3
|
0.36 €
|
89.29 %
|
88.62 %
|
88.06 %
|
5
|
N05CF01
|
Zopiclona
|
28.0
|
1.44
|
21.5
|
0.77 €
|
47.3
|
2.62
|
38.7
|
0.79 €
|
59.20 %
|
54.87 %
|
55.56 %
|
6
|
M01AH05
|
Etoricoxib
|
25.2
|
0.50
|
30.6
|
1.21 €
|
51.7
|
1.07
|
62.4
|
1.21 €
|
48.74 %
|
46.61 %
|
49.04 %
|
7
|
N06AA12
|
Doxepin
|
24.2
|
0.77
|
13.1
|
0.54 €
|
54.2
|
1.68
|
29.1
|
0.52 €
|
44.65 %
|
45.71 %
|
45.07 %
|
8
|
G04BD08
|
Solifenacin
|
22.6
|
0.24
|
32.5
|
1.44 €
|
31.3
|
0.33
|
44.8
|
1.43 €
|
72.20 %
|
72.84 %
|
72.54 %
|
9
|
N05CF02
|
Zolpidema
|
21.3
|
1.09
|
16.3
|
0.77 €
|
32.5
|
1.81
|
26.7
|
0.78 €
|
65.54 %
|
60.36 %
|
61.14 %
|
10
|
N06BX03
|
Piracetam
|
18.3
|
0.41
|
8.2
|
0.45 €
|
20.6
|
0.48
|
9.7
|
0.45 €
|
88.83 %
|
85.85 %
|
84.86 %
|
11
|
C04AD03
|
Pentoxifylline
|
15.0
|
0.35
|
7.2
|
0.48 €
|
17.7
|
0.57
|
11.0
|
0.54 €
|
84.75 %
|
61.29 %
|
65.61 %
|
12
|
N05BA08
|
Bromazepam
|
14.9
|
0.66
|
8.6
|
0.58 €
|
21.2
|
1.04
|
13.5
|
0.60 €
|
70.28 %
|
63.40 %
|
63.65 %
|
13
|
N06AA06
|
Trimipramine
|
14.6
|
0.49
|
10.8
|
0.74 €
|
31.6
|
1.12
|
24.5
|
0.73 €
|
46.20 %
|
43.66 %
|
44.17 %
|
14
|
N05BA01
|
Diazepam
|
13.1
|
0.53
|
6.0
|
0.46 €
|
31.0
|
1.30
|
15.3
|
0.47 €
|
42.26 %
|
40.71 %
|
39.16 %
|
15
|
N05CD06
|
Lormetazepama
|
12.5
|
0.38
|
5.2
|
0.42 €
|
15.3
|
0.51
|
7.0
|
0.42 €
|
81.70 %
|
74.50 %
|
74.20 %
|
16
|
C02CA08
|
Terazosin
|
12.3
|
0.19
|
6.6
|
0.54 €
|
8.0
|
0.24
|
8.2
|
0.56 €
|
-b
|
-
|
-
|
17
|
C02AC01
|
Clonidine
|
11.7
|
0.33
|
5.9
|
0.50 €
|
17.7
|
0.71
|
13.5
|
0.34 €
|
66.10 %
|
46.72 %
|
43.86 %
|
18
|
C02LA01
|
Reserpine and Diuretics
|
11.3
|
0.12
|
4.7
|
0.42 €
|
13.1
|
0.14
|
5.5
|
0.42 €
|
86.26 %
|
88.82 %
|
85.45 %
|
19
|
C01BC04
|
Flecainide
|
9.7
|
0.22
|
11.4
|
1.18 €
|
14.1
|
0.34
|
17.5
|
1.17 €
|
68.79 %
|
64.05 %
|
65.30 %
|
20
|
G04BD04
|
Oxybutynin
|
9.3
|
0.30
|
8.8
|
0.95 €
|
11.3
|
0.45
|
15.1
|
0.95 €
|
82.30 %
|
66.64 %
|
58.14 %
|
21
|
M01AC06
|
Meloxicam
|
9.3
|
0.21
|
3.3
|
0.35 €
|
14.8
|
0.41
|
6.3
|
0.38 €
|
62.84 %
|
50.66 %
|
52.12 %
|
22
|
N06AB03
|
Fluoxetine
|
8.8
|
0.10
|
2.9
|
0.33 €
|
43.3
|
0.58
|
17.3
|
0.32 €
|
20.32 %
|
17.32 %
|
16.79 %
|
23
|
M01AB01
|
Indometacin
|
8.7
|
0.25
|
4.0
|
0.46 €
|
14.2
|
0.53
|
8.6
|
0.48 €
|
61.27 %
|
47.36 %
|
46.63 %
|
24
|
C01AA08
|
Metildigoxin
|
8.4
|
0.17
|
2.7
|
0.32 €
|
9.5
|
0.20
|
3.0
|
0.32 €
|
88.42 %
|
86.65 %
|
90.00 %
|
25
|
M03BX07
|
Tetrazepam
|
8.3
|
0.57
|
8.0
|
0.96 €
|
22.0
|
2.08
|
26.8
|
1.19 €
|
37.73 %
|
27.46 %
|
29.90 %
|
26
|
C04AX21
|
Naftidrofuryl
|
7.5
|
0.34
|
8.2
|
1.09 €
|
9.0
|
0.43
|
10.2
|
1.11 €
|
83.33 %
|
78.49 %
|
80.17 %
|
27
|
C08CA05
|
Nifedipinea
|
6.5
|
0.26
|
3.8
|
0.58 €
|
69.7
|
1.32
|
22.2
|
0.29 €
|
9.33 %
|
19.70 %
|
17.11 %
|
28
|
M01AB11
|
Acemetacin
|
6.4
|
0.16
|
4.9
|
0.77 €
|
9.8
|
0.28
|
8.3
|
0.80 €
|
65.31 %
|
56.34 %
|
58.76 %
|
29
|
M03BX01
|
Baclofen
|
6.0
|
0.26
|
5.2
|
0.87 €
|
17.1
|
0.66
|
16.1
|
0.93 €
|
35.09 %
|
39.12 %
|
32.31 %
|
30
|
J01XE01
|
Nitrofurantoin
|
5.4
|
0.26
|
4.1
|
0.76 €
|
8.7
|
0.43
|
6.7
|
0.85 €
|
62.07 %
|
59.99 %
|
61.45 %
|
Sum Top30
| | |
502.9
|
13.75
|
305.7
| |
864.40
|
26.15
|
562.71
| |
58.18 %
|
52.59 %
|
54.33 %
|
Sum all 83 agents
| | |
598.7
|
16.93
|
387.8
| |
1,124.00
|
37.71
|
1,037.37
| |
53.27 %
|
44.89 %
|
37.38 %
|
- aPRISCUS agents which are potentially inappropriate at certain dose or release form
- bThe PPR does include the 3,000 top-selling drugs. Several traded products with terazosin as agent are sold less frequently and therefore not included. The published amount of DDD of terazosin is lower than the share of DDD taken by the elderlies. Consequently, calculation is misleading